Connect Biopharma Holdings
CNTB
20 hedge funds and large institutions have $467M invested in Connect Biopharma Holdings in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
50% more capital inflows, than outflows
Capital inflows: $22.4M | Capital outflows: $14.9M
25% more funds holding
Funds holding: 16 → 20 (+4)
0.56% more ownership
Funds ownership: 33.18% → 33.74% (+0.56%)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.2M |
| 2 |
ExodusPoint Capital Management
New York
|
+$439K |
| 3 |
State Street
Boston,
Massachusetts
|
+$397K |
| 4 |
Parkwood LLC
Cleveland,
Ohio
|
+$350K |
| 5 |
Janus Henderson Group
London,
|
+$274K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.77M |
| 2 |
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.39M |
| 3 |
Octagon Capital Advisors
New York
|
-$1.07M |
| 4 |
Millennium Management
New York
|
-$837K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$254K |
CNTB Hedge Fund Activity: Q3 2021 in Review
20 of the 5,732 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q3 2021, worth a combined $467M — up 26% from $372M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CNTB positions and 4 closed out — a net gain of 4 holders — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $20.2M. The largest seller was Wellington Management Group, cutting an estimated $8.77M.
- 20 institutional investors held Connect Biopharma Holdings (CNTB) as of Q3 2021, up from 16 in Q2 2021.
- Funds reported $467M of Connect Biopharma Holdings stock for Q3 2021, up 26% quarter-over-quarter.
- 8 funds opened new Connect Biopharma Holdings positions in Q3 2021 and 4 closed out, a net change of +4 holders.
- The largest Connect Biopharma Holdings buyer in Q3 2021 was Fidelity Investments, an estimated $20.2M added.
- The largest Connect Biopharma Holdings seller in Q3 2021 was Wellington Management Group, an estimated $8.77M sold.
Based on aggregated 13F filings for Q3 2021.